home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Novel Antibiotic Fights Hospital Killers

  May, 24 2006 7:17
your information resource in human molecular genetics
In a much-needed blow against rising antibiotic resistance, a team led by Jun Wang report in the 18 May 06 issue of Nature (Vol. 441, No. 7091, pp. 358-361) that it has discovered a potent natural antibiotic that kills many Gram-positive bacteria, including some of the biggest hospital threats: methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE).

The researchers screened 250,000 natural product extracts in whole-cell and biochemical assays, and hit upon platensimycin, a small molecule manufactured by a strain of Streptomyces platensis from a South African soil sample.

Platensimycin, which represents a previously unknown class of antibiotics, acts by blocking enzymes involved in the synthesis of fatty acids, the building blocks of lipids. No existing antibiotics target fatty-acid synthesis in this way. The antibiotic clears mice of S. aureus infection and does not appear to cause toxic side effects.


Marjorie Moeling (Director, Merck Research Laboratories Communications & Policy)
E-mail: marjorie_moeling@merck.com

Eric D. Brown (McMaster University, Hamilton, Canada)
E-mail: ebrown@mcmaster.ca

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.